Form 4: Senseonics CMO Sells Shares for Tax Obligations
Insider Trading Report
Senseonics Holdings, Inc.'s Chief Medical Officer, Francine Kaufman, disposed of 4,605 common shares to cover tax obligations related to restricted stock unit vesting.
Summary
- Francine Kaufman, Chief Medical Officer and Director of Senseonics Holdings, Inc., disposed of 4,605 shares of common stock.
- The transaction occurred on November 15, 2025, at a price of $6.26 per share.
- These shares were withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.
- Following this transaction, Kaufman beneficially owns 123,948 shares of common stock.
- The reported share numbers reflect a 1-for-20 reverse stock split effected by Senseonics Holdings, Inc. on October 17, 2025.
Sentiment
Score: 5
Explanation: The transaction is a routine insider disposition for tax purposes related to RSU vesting, which is neutral in terms of company performance or strategic direction. The reverse stock split is noted as a factual adjustment.
Positives
- The transaction is a routine event related to restricted stock unit (RSU) vesting, indicating that previously granted equity compensation has matured.
Negatives
- An insider disposed of shares, albeit for tax purposes, which reduces their direct ownership slightly.
Future Outlook
No forward-looking statements or guidance are provided in this filing.
Industry Context
This is a routine insider transaction for tax purposes, common across all industries when restricted stock units vest. It does not provide specific insights into broader industry trends or competitive landscape.
Related Party Transactions
- The transaction involves the disposition of shares by an officer and director to the company to satisfy tax withholding obligations related to equity compensation, which is a common type of related party transaction in this context.
Stakeholder Impact
- Shareholders: The transaction is a routine administrative event and does not indicate a significant change in company value or strategy. The reverse stock split impacts the number of shares and price per share but not the overall value of holdings.
- Employees: This reflects the standard process for equity compensation vesting and tax handling for company executives.
Key Dates
| Date | Description |
|---|---|
| 09/13/2025 | Date Francine R. Kaufman executed the Power of Attorney for SEC filings. |
| 10/17/2025 | Effective date of Senseonics Holdings, Inc.'s 1-for-20 reverse stock split. |
| 11/15/2025 | Date of common stock disposition by Francine Kaufman to satisfy tax obligations. |
| 11/18/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe filing details a routine insider transaction where shares were disposed of to cover tax obligations from restricted stock unit vesting. This is a standard administrative event and does not reflect a change in the company's fundamentals, strategic direction, or management's confidence. The mention of a reverse stock split is a factual adjustment to share numbers, not a new event. Therefore, it provides no new information to warrant a change in investment recommendation.
Keywords
Senseonics Holdings, SENS, Form 4, Insider Transaction, Francine Kaufman, Chief Medical Officer, Restricted Stock Units, Tax Withholding, Reverse Stock Split, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.